Switch theme
Sign up to access all valuation multiples
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
2012
13.8K+
LTM Revenue $9.3B
LTM EBITDA $4.0B
$80.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zoetis has a last 12-month revenue (LTM) of $9.3B and a last 12-month EBITDA of $4.0B.
In the most recent fiscal year, Zoetis achieved revenue of $9.3B and an EBITDA of $3.9B.
Zoetis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zoetis valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $9.3B | XXX | $9.3B | XXX | XXX | XXX |
| Gross Profit | $6.6B | XXX | $6.5B | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 71% | XXX | XXX | XXX |
| EBITDA | $4.0B | XXX | $3.9B | XXX | XXX | XXX |
| EBITDA Margin | 43% | XXX | 42% | XXX | XXX | XXX |
| EBIT | $3.6B | XXX | $3.4B | XXX | XXX | XXX |
| EBIT Margin | 38% | XXX | 37% | XXX | XXX | XXX |
| Net Profit | $2.7B | XXX | $2.5B | XXX | XXX | XXX |
| Net Margin | 29% | XXX | 27% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $4.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Zoetis's stock price is $169.
Zoetis has current market cap of $75.1B, and EV of $80.1B.
See Zoetis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $80.1B | $75.1B | XXX | XXX | XXX | XXX | $6.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Zoetis has market cap of $75.1B and EV of $80.1B.
Zoetis's trades at 8.7x EV/Revenue multiple, and 20.8x EV/EBITDA.
Equity research analysts estimate Zoetis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zoetis has a P/E ratio of 27.5x.
See valuation multiples for Zoetis and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $75.1B | XXX | $75.1B | XXX | XXX | XXX |
| EV (current) | $80.1B | XXX | $80.1B | XXX | XXX | XXX |
| EV/Revenue | 8.6x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | 20.0x | XXX | 20.8x | XXX | XXX | XXX |
| EV/EBIT | 22.4x | XXX | 23.6x | XXX | XXX | XXX |
| EV/Gross Profit | 12.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.5x | XXX | 30.2x | XXX | XXX | XXX |
| EV/FCF | 32.5x | XXX | 34.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialZoetis's last 12 month revenue growth is 4%
Zoetis's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.2M for the same period.
Zoetis's rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zoetis's rule of X is 53% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Zoetis and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 43% | XXX | 42% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | 47% | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 53% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Mad Paws | XXX | XXX | XXX | XXX | XXX | XXX |
| i-Tail | XXX | XXX | XXX | XXX | XXX | XXX |
| Central Garden & Pet | XXX | XXX | XXX | XXX | XXX | XXX |
| Dogness | XXX | XXX | XXX | XXX | XXX | XXX |
| Freshpet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zoetis acquired XXX companies to date.
Last acquisition by Zoetis was XXXXXXXX, XXXXX XXXXX XXXXXX . Zoetis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Zoetis founded? | Zoetis was founded in 2012. |
| Where is Zoetis headquartered? | Zoetis is headquartered in United States of America. |
| How many employees does Zoetis have? | As of today, Zoetis has 13.8K+ employees. |
| Who is the CEO of Zoetis? | Zoetis's CEO is Ms. Kristin C. Peck. |
| Is Zoetis publicy listed? | Yes, Zoetis is a public company listed on NYS. |
| What is the stock symbol of Zoetis? | Zoetis trades under ZTS ticker. |
| When did Zoetis go public? | Zoetis went public in 2013. |
| Who are competitors of Zoetis? | Similar companies to Zoetis include e.g. Mad Paws, i-Tail, Central Garden & Pet, Dogness. |
| What is the current market cap of Zoetis? | Zoetis's current market cap is $75.1B |
| What is the current revenue of Zoetis? | Zoetis's last 12 months revenue is $9.3B. |
| What is the current revenue growth of Zoetis? | Zoetis revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Zoetis? | Current revenue multiple of Zoetis is 8.6x. |
| Is Zoetis profitable? | Yes, Zoetis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Zoetis? | Zoetis's last 12 months EBITDA is $4.0B. |
| What is Zoetis's EBITDA margin? | Zoetis's last 12 months EBITDA margin is 43%. |
| What is the current EV/EBITDA multiple of Zoetis? | Current EBITDA multiple of Zoetis is 20.0x. |
| What is the current FCF of Zoetis? | Zoetis's last 12 months FCF is $2.5B. |
| What is Zoetis's FCF margin? | Zoetis's last 12 months FCF margin is 26%. |
| What is the current EV/FCF multiple of Zoetis? | Current FCF multiple of Zoetis is 32.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
